Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Murine monoclonal antibody to Zika virus envelope protein

A monoclonal antibody, envelope protein technology, applied in the direction of antiviral immunoglobulin, immunoglobulin, peptide, etc., to achieve the effect of good specificity, strong neutralization activity, and enhanced anti-aggregation

Active Publication Date: 2021-09-28
武汉班科生物技术有限公司
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are no approved vaccines and specific drugs. Here we use the Zika virus envelope protein constructed by ourselves to immunize mice, and obtain a mouse-derived monoclonal antibody with strong neutralizing activity, which can be used in the future for Zika virus. prevention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Murine monoclonal antibody to Zika virus envelope protein
  • Murine monoclonal antibody to Zika virus envelope protein
  • Murine monoclonal antibody to Zika virus envelope protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1: Obtaining of B8 antibody sequence

[0016] Based on the constructed immunized mouse Fab phage display library, (the acquisition method of the library comes from the fusion protein of the envelope protein of Flaviviridae virus disclosed in Chinese patent application 201811613477.1 and its preparation method and application, using the fusion protein as an immunogen After immunizing the mice, we obtained the cDNA and used it as the construction material of the phage display library), we carried out three rounds of screening, and through the monoclonal phage ELISA, the positive clones were sequenced, and the bases of the B0 candidate clones were obtained sequence, and through the amino acid translation software (https: / / web.expasy.org / translate / ), the amino acid sequence was obtained, the amino acid sequence of the light chain is shown in SEQ No.1, and the amino acid sequence of the heavy chain is shown in SEQ No.2 shown. .

Embodiment 2

[0017] Example 2: Using Tango software to optimize the obtained B0 amino acid sequence

[0018] Use Tango software (http: / / tango.crg.es / ) to predict the aggregation-prone region of the amino acid sequence of the B0 candidate clone, and find that there is a strong aggregation-prone region, such as Picture 1-1 , so point mutation is carried out in this region to obtain B8 antibody, its light chain amino acid sequence is shown in SEQ No.1, its heavy chain amino acid sequence is shown in SEQ No.3, the corresponding base sequence, and the light chain is shown in SEQ No. 4, the heavy chain is shown in SEQ No.5. The mutated amino acid sequence was re-predicted by Tango software, and it was found that the aggregation-prone region was significantly improved, as shown in Figure 1-2 , 1-3.

Embodiment 3

[0019] Example 3: 293F cells express B8 antibody and detect it by SDS-PAGE

[0020] The mutated base sequence was cloned into the dual promoter vector pVitro2-neo-mcs (InvivoGen), and the 293F cells were transfected with PEI to express the protein. After 5-7 days of expression, the culture supernatant of the 293F cells was treated with ProteinA (GE) was purified, and after the purified protein was concentrated and exchanged, the B8 antibody dissolved in PBS buffer was obtained. After SDS-PAGE electrophoresis detection, it was found that it presented two bands of light chain and heavy chain, such as figure 2 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a mouse-derived monoclonal antibody of Zika virus envelope protein. After screening and genetic modification, the obtained antibody has good specificity, strong neutralizing activity, and increased anti-aggregation property, and is suitable for the Zika virus. prevention.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a mouse-derived monoclonal antibody of Zika virus envelope protein. Background technique [0002] Zika virus (ZIKV) is a virus of the family Flaviviridae. Infection with this virus can cause microcephaly in newborns and affect the neurodevelopment of infants. Guillain-Barré syndrome (GBS) may occur after infection in adults and lead to neurological disorders. damage. At present, there are no approved vaccines and specific drugs. Here we use the Zika virus envelope protein constructed by ourselves to immunize mice, and obtain a mouse-derived monoclonal antibody with strong neutralizing activity, which can be used in the future for Zika virus. Prevention and treatment. Contents of the invention [0003] The purpose of the present invention is to fill the gap in the prior art and provide a mouse-derived monoclonal antibody with good specificity to the envelope protein of Zika virus....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/10C12N15/13
CPCC07K16/1081C07K2317/51C07K2317/515C07K2317/76
Inventor 龚睿
Owner 武汉班科生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com